Literature DB >> 21270517

Selective targeting of histone methylation.

Abul B M M K Islam1, William F Richter, Nuria Lopez-Bigas, Elizaveta V Benevolenskaya.   

Abstract

Histones are post-translationally modified by multiple histone-modifying enzymes, which in turn influences gene expression. Much of the work in the field to date has focused on genetic, biochemical and structural characterization of these enzymes. The most recent genome-wide methods provide insights into specific recruitment of histone-modifying enzymes in vivo and, therefore, onto mechanisms of establishing a differential expression pattern. Here we focus on the recruitment mechanisms of the enzymes involved in the placement of two contrasting histone marks, histone H3 lysine 4 (H3K4) methylation and histone H3 lysine 27 (H3K27) methylation. We describe distribution of their binding sites and show that recruitment of different histone-modifying proteins can be coordinated, opposed, or alternating. Specifically, genomic sites of the H3K4 histone demethylase KDM5A become accessible to its homolog KDM5B in cells with a lowered KDM5A level. The currently available data on recruitment of H3K4/H3K27 modifying enzymes suggests that the formed protein complexes are targeted in a sequential and temporal manner, but that additional, still unknown, interactions contribute to targeting specificity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270517      PMCID: PMC3115016          DOI: 10.4161/cc.10.3.14705

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  94 in total

1.  Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.

Authors:  Elizaveta V Benevolenskaya; Heather L Murray; Philip Branton; Richard A Young; William G Kaelin
Journal:  Mol Cell       Date:  2005-06-10       Impact factor: 17.970

2.  Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.

Authors:  Thomas A Milne; Mary Ellen Martin; Hugh W Brock; Robert K Slany; Jay L Hess
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

3.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

4.  Polycomb complexes repress developmental regulators in murine embryonic stem cells.

Authors:  Laurie A Boyer; Kathrin Plath; Julia Zeitlinger; Tobias Brambrink; Lea A Medeiros; Tong Ihn Lee; Stuart S Levine; Marius Wernig; Adriana Tajonar; Mridula K Ray; George W Bell; Arie P Otte; Miguel Vidal; David K Gifford; Richard A Young; Rudolf Jaenisch
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

5.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

6.  A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

Authors:  Bradley E Bernstein; Tarjei S Mikkelsen; Xiaohui Xie; Michael Kamal; Dana J Huebert; James Cuff; Ben Fry; Alex Meissner; Marius Wernig; Kathrin Plath; Rudolf Jaenisch; Alexandre Wagschal; Robert Feil; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

7.  Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene.

Authors:  Laura J C M van Zutven; Emine Onen; Sandra C J M Velthuizen; Ellen van Drunen; Anne R M von Bergh; Marry M van den Heuvel-Eibrink; Angelo Veronese; Cristina Mecucci; Massimo Negrini; Georgine E de Greef; H Berna Beverloo
Journal:  Genes Chromosomes Cancer       Date:  2006-05       Impact factor: 5.006

8.  Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1.

Authors:  Jérôme Déjardin; Aurélien Rappailles; Olivier Cuvier; Charlotte Grimaud; Martine Decoville; Daniel Locker; Giacomo Cavalli
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

9.  Global and Hox-specific roles for the MLL1 methyltransferase.

Authors:  Matthew G Guenther; Richard G Jenner; Brett Chevalier; Tatsuya Nakamura; Carlo M Croce; Eli Canaani; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-07       Impact factor: 11.205

10.  Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

Authors:  Yujiang Shi; Fei Lan; Caitlin Matson; Peter Mulligan; Johnathan R Whetstine; Philip A Cole; Robert A Casero; Yang Shi
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

View more
  16 in total

1.  Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A.

Authors:  Chandra-Prakash Chaturvedi; Brinda Somasundaram; Kulwant Singh; Richard L Carpenedo; William L Stanford; F Jeffrey Dilworth; Marjorie Brand
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

2.  Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).

Authors:  Ping-Pui Wong; Fabrizio Miranda; KaYi V Chan; Chiara Berlato; Helen C Hurst; Angelo G Scibetta
Journal:  Mol Cell Biol       Date:  2012-02-27       Impact factor: 4.272

3.  Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer.

Authors:  Lauren P Blair; Jian Cao; Mike Ran Zou; Joyce Sayegh; Qin Yan
Journal:  Cancers (Basel)       Date:  2011-03-01       Impact factor: 6.639

4.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Authors:  Michael L Beshiri; Katherine B Holmes; William F Richter; Samuel Hess; Abul B M M K Islam; Qin Yan; Lydia Plante; Larisa Litovchick; Nicolas Gévry; Nuria Lopez-Bigas; William G Kaelin; Elizaveta V Benevolenskaya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

5.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.

Authors:  Mike Ran Zou; Jian Cao; Zongzhi Liu; Sung Jin Huh; Kornelia Polyak; Qin Yan
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

Review 7.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

8.  Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

Authors:  Savita Sankar; Emily R Theisen; Jared Bearss; Timothy Mulvihill; Laura M Hoffman; Venkataswamy Sorna; Mary C Beckerle; Sunil Sharma; Stephen L Lessnick
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

9.  Enhancer-promoter interactions are encoded by complex genomic signatures on looping chromatin.

Authors:  Sean Whalen; Rebecca M Truty; Katherine S Pollard
Journal:  Nat Genet       Date:  2016-04-04       Impact factor: 38.330

10.  Co-regulation of histone-modifying enzymes in cancer.

Authors:  Abul B M M K Islam; William F Richter; Laura A Jacobs; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.